A letter from our CEO: Kanteron Systems is closing down.
Kanteron Systems has formally communicated its position to the USA Food and Drug Administration (FDA) regarding Document FDA-2021-N-0009-0001.
Kanteron Systems Bioinformatics department, in collaboration with scientists from several institutions (the University of Cambridge, Genomics England, Vall d’Hebron Institute of Oncology, and others) presented 2 posters at ESCS of the XIX European Conference on Computational Biology annual meeting which was held online due to CoViD19, August 31st – September 08, 2020.
Demonstrating a strong commitment to our partners, Microsoft, and the Microsoft Azure Cloud, Kanteron Systems’ Precision Medicine Platform is finally available in Microsoft Azure Marketplace and Microsoft AppSource.
Jorge Cortell, Kanteron Systems’ CEO, will be a keynote speaker at HIMSS, during the session “Be a Radical Changemaker!" September 11, 2020.
Kanteron Systems was founded on August 23rd 2005. We are always looking forward, but, just for a moment, let’s remember these amazing 15 years.
Kanteron Systems, OCBT, WeDoctor, Techbridge, and LFLogistics, have organized a webinar titled “Practical Application of New Technologies for Chronic Prostatitis Diagnosis and Treatment” for 28 August 2020, which will feature the presentation “Precision Medicine Platform: How AI can assist Faster Diagnosis and Precise Treatments” by Jorge Cortell, CEO of Kanteron Systems, and the presentation “A Urine-based New Biomarker for Chronic Protatitis/Chronic Pelvic Pain Syndrome” by Dr. Zeng, Professor of Pathology in China’s Military 960 Hospital.
